Literature DB >> 24614264

Association between neuropathology and brain volume in the Framingham Heart Study.

Berneet Kaur1, Jayandra J Himali, Sudha Seshadri, Alexa S Beiser, Rhoda Au, Ann C McKee, Sanford Auerbach, Philip A Wolf, Charles S DeCarli.   

Abstract

Studies of clinical and community cohorts have shown that antemortem imaging measures of hippocampal volume have correlated with postmortem Alzheimer pathology. Fewer studies have examined the relationship between both Alzheimer and cerebrovascular pathology, and antemortem brain imaging. The aim of this study was to correlate antemortem brain magnetic resonance imaging (MRI) volumes with postmortem brain pathology (both Alzheimer-related and cerebrovascular) in a community-derived cohort from the Framingham Heart Study. Participants (n=59) from the Framingham Heart Study were included if they were enrolled in the brain autopsy program and underwent antemortem clinical evaluation, neuropsychological testing, and brain MRI. Cortical neurofibrillary tangle pathology correlated with lower total cerebral brain (β±SE=-0.04±0.01, P=0.004) and hippocampal volumes (β±SE=-0.03±0.02, P=0.044) and larger temporal horns (log-transformed, β±SE=0.05±0.01, P=0.001). Similar findings were seen between total/cortical neuritic plaques and total cerebral brain and temporal horn volume. White matter hyperintensities (also log-transformed) were best predicted by the presence of deep nuclei microinfarcts (β±SE=0.53±0.21, P=0.016), whereas hippocampal volume was significantly decreased in the presence of hippocampal sclerosis (β±SE=-1.23±0.30, P<0.001). This study showed that volumetric MRI measures correlated with postmortem Alzheimer-related and cerebrovascular neuropathology in this community-derived cohort, confirming that these MRI measures are important antemortem surrogates for these dementia-related pathologies.

Entities:  

Mesh:

Year:  2014        PMID: 24614264      PMCID: PMC4139422          DOI: 10.1097/WAD.0000000000000032

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  36 in total

1.  Managing and analysing data from a large-scale study on Framingham Offspring relating brain structure to cognitive function.

Authors:  Joseph M Massaro; Ralph B D'Agostino; Lisa M Sullivan; Alexa Beiser; Charles DeCarli; Rhoda Au; Merrill F Elias; Philip A Wolf
Journal:  Stat Med       Date:  2004-01-30       Impact factor: 2.373

2.  Method for quantification of brain, ventricular, and subarachnoid CSF volumes from MR images.

Authors:  C DeCarli; J Maisog; D G Murphy; D Teichberg; S I Rapoport; B Horwitz
Journal:  J Comput Assist Tomogr       Date:  1992 Mar-Apr       Impact factor: 1.826

3.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

4.  Hippocampal volume as an index of Alzheimer neuropathology: findings from the Nun Study.

Authors:  K M Gosche; J A Mortimer; C D Smith; W R Markesbery; D A Snowdon
Journal:  Neurology       Date:  2002-05-28       Impact factor: 9.910

5.  Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro.

Authors:  A Beiser; R B D'Agostino; S Seshadri; L M Sullivan; P A Wolf
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

6.  Predictors of brain morphology for the men of the NHLBI twin study.

Authors:  C DeCarli; B L Miller; G E Swan; T Reed; P A Wolf; J Garner; L Jack; D Carmelli
Journal:  Stroke       Date:  1999-03       Impact factor: 7.914

7.  Changes in premorbid brain volume predict Alzheimer's disease pathology.

Authors:  L C Silbert; J F Quinn; M M Moore; E Corbridge; M J Ball; G Murdoch; G Sexton; J A Kaye
Journal:  Neurology       Date:  2003-08-26       Impact factor: 9.910

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study.

Authors:  D L Bachman; P A Wolf; R Linn; J E Knoefel; J Cobb; A Belanger; R B D'Agostino; L R White
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

10.  Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study.

Authors:  Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli
Journal:  Stroke       Date:  2004-06-24       Impact factor: 7.914

View more
  19 in total

1.  Subclinical cerebrovascular disease inversely associates with learning ability: The NOMAS.

Authors:  Hilary Glazer; Chuanhui Dong; Mitsuhiro Yoshita; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Charles DeCarli; Yaakov Stern; Clinton B Wright
Journal:  Neurology       Date:  2015-05-22       Impact factor: 9.910

Review 2.  Obstructive Sleep Apnea and the Brain: a Focus on Gray and White Matter Structure.

Authors:  Andrée-Ann Baril; Marie-Ève Martineau-Dussault; Erlan Sanchez; Claire André; Cynthia Thompson; Julie Legault; Nadia Gosselin
Journal:  Curr Neurol Neurosci Rep       Date:  2021-02-14       Impact factor: 5.081

3.  White Matter Hyperintensity Associations with Cerebral Blood Flow in Elderly Subjects Stratified by Cerebrovascular Risk.

Authors:  Ahmed A Bahrani; David K Powell; Guoquiang Yu; Eleanor S Johnson; Gregory A Jicha; Charles D Smith
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-01-04       Impact factor: 2.136

4.  Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.

Authors:  Daniel T Ohm; Angela J Fought; Alfred Rademaker; Garam Kim; Jaiashre Sridhar; Christina Coventry; Tamar Gefen; Sandra Weintraub; Eileen Bigio; Marek Marsel Mesulam; Emily Rogalski; Changiz Geula
Journal:  Brain Pathol       Date:  2019-09-12       Impact factor: 6.508

5.  Neuropathologic correlates of regional brain volumes in a community cohort of older adults.

Authors:  Aikaterini Kotrotsou; Julie A Schneider; David A Bennett; Sue E Leurgans; Robert J Dawe; Patricia A Boyle; Tom Golak; Konstantinos Arfanakis
Journal:  Neurobiol Aging       Date:  2015-06-30       Impact factor: 4.673

6.  The relationship between amyloid deposition, neurodegeneration, and cognitive decline in dementia.

Authors:  Rik Vandenberghe
Journal:  Curr Neurol Neurosci Rep       Date:  2014-11       Impact factor: 5.081

7.  Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.

Authors:  Robin de Flores; Laura E M Wisse; Sandhitsu R Das; Long Xie; Corey T McMillan; John Q Trojanowski; John L Robinson; Murray Grossman; Edward Lee; David J Irwin; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2020-04-22       Impact factor: 21.566

8.  Whole genome sequence analyses of brain imaging measures in the Framingham Study.

Authors:  Chloé Sarnowski; Claudia L Satizabal; Charles DeCarli; Achilleas N Pitsillides; L Adrienne Cupples; Ramachandran S Vasan; James G Wilson; Joshua C Bis; Myriam Fornage; Alexa S Beiser; Anita L DeStefano; Josée Dupuis; Sudha Seshadri
Journal:  Neurology       Date:  2017-12-27       Impact factor: 9.910

9.  Slow-Wave Sleep and MRI Markers of Brain Aging in a Community-Based Sample.

Authors:  Andrée-Ann Baril; Alexa S Beiser; Vincent Mysliwiec; Erlan Sanchez; Charles S DeCarli; Susan Redline; Daniel J Gottlieb; Pauline Maillard; Jose Rafael Romero; Claudia L Satizabal; Jared M Zucker; Sudha Seshadri; Matthew P Pase; Jayandra J Himali
Journal:  Neurology       Date:  2020-12-22       Impact factor: 9.910

10.  Cortical tau load is associated with white matter hyperintensities.

Authors:  Kirsty E McAleese; Michael Firbank; Madhurima Dey; Sean J Colloby; Lauren Walker; Mary Johnson; Joshua R Beverley; John Paul Taylor; Alan J Thomas; John T O'Brien; Johannes Attems
Journal:  Acta Neuropathol Commun       Date:  2015-09-30       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.